November 2025

Reasons for Loss to Follow-Up in Thai Glaucoma Patients and Suspects Glaucoma is a leading cause of irreversible blindness worldwide, and Thailand is no exception. Early detection and consistent follow-up are crucial to preventing vision loss. However, many Thai glaucoma patients and suspects fail to return for scheduled appointments, leading to disease progression and poorer […]

TLR4 Deficiency Does Not Affect Glaucoma Progression in Mice Glaucoma is a leading cause of irreversible blindness worldwide, characterized by progressive optic nerve damage and retinal ganglion cell (RGC) loss. While elevated intraocular pressure (IOP) is a major risk factor, the underlying molecular mechanisms remain incompletely understood. Recent studies have explored the role of innate

Top Advances in Nonimplant MIGS for Glaucoma Treatment Glaucoma, a leading cause of irreversible blindness worldwide, has seen significant advancements in treatment options over the past decade. Among these, Minimally Invasive Glaucoma Surgery (MIGS) has emerged as a game-changer, offering safer and less invasive alternatives to traditional surgeries. While implant-based MIGS devices have gained attention,

BrightFocus Foundation Awards $13M for Alzheimer’s and Eye Disease Research In a groundbreaking move to advance medical research, the BrightFocus Foundation has announced the allocation of $13 million in grants to support cutting-edge studies on Alzheimer’s disease and eye diseases. This significant investment underscores the foundation’s commitment to accelerating breakthroughs in neurodegenerative and vision-related conditions,

Minimally Invasive Glaucoma Treatments Show Promising Advances Glaucoma, often called the “silent thief of sight,” is a leading cause of irreversible blindness worldwide. Traditional treatments like eye drops, laser therapy, and invasive surgeries have been the mainstay for decades. However, recent advancements in minimally invasive glaucoma treatments (MIGS) are revolutionizing how this condition is managed.

How Intraoperative Fluorescein Angiography Enhances RWC 2025 Surgical Outcomes In the rapidly evolving field of surgical medicine, advancements in imaging technologies are revolutionizing patient outcomes. One such breakthrough is intraoperative fluorescein angiography (IFA), a real-time imaging technique that is transforming surgical precision, particularly in complex procedures like those anticipated in the RWC 2025 (Robotic and

Perfuse Therapeutics Reports Positive Phase 1/2a Results for PER-001 Glaucoma Implant In a significant breakthrough for glaucoma treatment, Perfuse Therapeutics has announced encouraging results from its Phase 1/2a clinical trial for PER-001, a novel implant designed to manage intraocular pressure (IOP) in glaucoma patients. The study demonstrated both safety and efficacy, marking a promising step

Vitamin Supplements May Slow Glaucoma Progression, Study Finds Glaucoma is a leading cause of irreversible blindness worldwide, affecting millions of people. While treatments like eye drops, laser therapy, and surgery aim to lower intraocular pressure (IOP), researchers are constantly exploring new ways to slow disease progression. A recent study suggests that vitamin supplements could play